Sort
11,323 grants matching “glioblastoma”
Role of uPA and uPAR in Human Glioma Invasiveness
$231,475Jasti S Rao · University Of Illinois At Chicago · R01 · FY2008 · CA
Role of uPA and uPAR in Human Glioma Invasiveness
$231,475Jasti S Rao · University Of Illinois At Chicago · R01 · FY2009 · CA
Role of uPA and uPAR in Human Glioma Invasiveness
$231,475Jasti S Rao · University Of Illinois At Chicago · R01 · FY2007 · CA
High throughput bioluminescence screening for glioma therapeutics
$231,438Bakhos A. Tannous · Massachusetts General Hospital · R21 · FY2009 · NS
Advanced prediction of GBM recurrence (TIME) for personalized radiotherapy
$231,412Wensha Yang · University Of California, San Francisco · R21 · FY2022 · CA
Rheb GTPase as chemotherapeutic target for brain tumors
$231,339Lawrence A Quilliam · Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2006 · CA
Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas
$231,253Juan C Vasquez · Yale University · K08 · FY2025 · CA
Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas
$231,253Juan C Vasquez · Yale University · K08 · FY2024 · CA
Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas
$231,253Juan C Vasquez · Yale University · K08 · FY2022 · CA
Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas
$231,253Juan C Vasquez · Yale University · K08 · FY2023 · CA
Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas
$231,253Juan C Vasquez · Yale University · K08 · FY2021 · CA
How do you build an astrocyte?
$231,000Marc R Freeman · Oregon Health & Science University · R21 · FY2023 · MH
Neural Progenitor Genes and Brain Tumors
$231,000Harley I Kornblum · University Of California Los Angeles · R56 · FY2010 · NS
Combinatorial engineering of a three-cell synthetic immunotherapy system
$231,000Kyle Gabriel Daniels · Stanford University · R21 · FY2025 · EB
Engineered microenvironments as biomimetic culture platforms for studying the role of brain extracellular matrix in acquisition of resistance to EGFR inhibition across multiple biological scales
$231,000Stephanie Kristin Seidlits · University Of California Los Angeles · R21 · FY2015 · NS
Developing mathematical model driven optimized recurrent glioblastoma therapies
$230,992Heiko Enderling · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2021 · CA
Serum exosome biomarkers for evaluation of glioma drug response
$230,985Xandra Owens Breakefield · Massachusetts General Hospital · R21 · FY2011 · CA
Drug Sensitivity of Calcium Modulators from Brain Tumor
$230,864Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2003 · CA
Mechanisms of Herbal Radiosensitization of Glioma Cells
$230,663California Pacific Med Ctr Res Institute · R01 · FY2002 · AT
Experimental Therapeutics for Brain Cancer
$230,659Daniel A Vallera · University Of Minnesota · R01 · FY2006 · CA
Novel Nano-Plasmonic Technology for Quantitative Analysis of Cancer Exosomes
$230,637Hyungsoon Im · Massachusetts General Hospital · R00 · FY2018 · CA
High-Grade Astrocytoma-specific Molecular Targeting
$230,637Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2013 · CA
New Vectors and Delivery Systems for Glioblastoma Therapy
$230,612Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2006 · CA
Novel MRI Vascular Biomarkers for the Detection of Tumor Invasion
$230,600Christian T Farrar · Massachusetts General Hospital · R21 · FY2011 · CA
RATIONAL DEVELOPMENT OF GSTP1-TARGETED ANTI-GLIOMA THERAPEUTICS
$230,536Francis Ali-Osman · Duke University · P50 · FY2007 · CA